Cargando…

Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNγ immunity

BACKGROUND: Inborn errors of IL-12/IL-23-IFNγ immunity underlie Mendelian susceptibility to mycobacterial diseases (MSMD), a group of immunodeficiencies characterized by a highly selective susceptibility to weakly virulent strains of mycobacteria, such as non-tuberculous mycobacteria (NTM) and bacil...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolezalova, Karolina, Strachan, Tomas, Matej, Radoslav, Ricna, Dita, Bloomfield, Marketa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Libbey Eurotext 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465665/
https://www.ncbi.nlm.nih.gov/pubmed/36069176
http://dx.doi.org/10.1684/ejd.2022.4281
_version_ 1784787849168551936
author Dolezalova, Karolina
Strachan, Tomas
Matej, Radoslav
Ricna, Dita
Bloomfield, Marketa
author_facet Dolezalova, Karolina
Strachan, Tomas
Matej, Radoslav
Ricna, Dita
Bloomfield, Marketa
author_sort Dolezalova, Karolina
collection PubMed
description BACKGROUND: Inborn errors of IL-12/IL-23-IFNγ immunity underlie Mendelian susceptibility to mycobacterial diseases (MSMD), a group of immunodeficiencies characterized by a highly selective susceptibility to weakly virulent strains of mycobacteria, such as non-tuberculous mycobacteria (NTM) and bacillus Calmette-Guérin (BCG). Cutaneous mycobacterial infections are common in MSMD and may represent a red flag for this immunodeficiency. OBJECTIVES: We present a case series of four paediatric patients with MSMD, specifically with IFNγR1 and STAT1 deficiencies, and cutaneous NtM/BCG infections to increase awareness of this immunodeficiency, which may, in some cases, be intercepted by the dermatologist and thus timely referred to the immunologist. MATERIALS & METHODS: Clinical, laboratory and genetic investigations of the four paediatric patients with MSMD are presented. RESULTS: All four presented patients experienced early complications after BCG vaccination. Two patients suffered recurrent mycobacteriosis, one patient experienced delayed BCG reactivation, and one patient died of disseminated avian mycobacteriosis. The dermatological manifestation in these patients included destructive nasal ulcerations, scrofuloderma of various sites and lupus vulgaris. All patients had a normal basic immune phenotype. CONCLUSION: The presented cases demonstrate that NTM/BCG infections in otherwise seemingly immunocompetent patients should raise suspicion of MSMD. This is of utmost importance as specific therapeutic approaches, such as IFNγ treatment or haematopoietic stem cell transplantation, may be employed to improve the disease outcome.
format Online
Article
Text
id pubmed-9465665
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Libbey Eurotext
record_format MEDLINE/PubMed
spelling pubmed-94656652022-09-12 Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNγ immunity Dolezalova, Karolina Strachan, Tomas Matej, Radoslav Ricna, Dita Bloomfield, Marketa Eur J Dermatol Clinical Report BACKGROUND: Inborn errors of IL-12/IL-23-IFNγ immunity underlie Mendelian susceptibility to mycobacterial diseases (MSMD), a group of immunodeficiencies characterized by a highly selective susceptibility to weakly virulent strains of mycobacteria, such as non-tuberculous mycobacteria (NTM) and bacillus Calmette-Guérin (BCG). Cutaneous mycobacterial infections are common in MSMD and may represent a red flag for this immunodeficiency. OBJECTIVES: We present a case series of four paediatric patients with MSMD, specifically with IFNγR1 and STAT1 deficiencies, and cutaneous NtM/BCG infections to increase awareness of this immunodeficiency, which may, in some cases, be intercepted by the dermatologist and thus timely referred to the immunologist. MATERIALS & METHODS: Clinical, laboratory and genetic investigations of the four paediatric patients with MSMD are presented. RESULTS: All four presented patients experienced early complications after BCG vaccination. Two patients suffered recurrent mycobacteriosis, one patient experienced delayed BCG reactivation, and one patient died of disseminated avian mycobacteriosis. The dermatological manifestation in these patients included destructive nasal ulcerations, scrofuloderma of various sites and lupus vulgaris. All patients had a normal basic immune phenotype. CONCLUSION: The presented cases demonstrate that NTM/BCG infections in otherwise seemingly immunocompetent patients should raise suspicion of MSMD. This is of utmost importance as specific therapeutic approaches, such as IFNγ treatment or haematopoietic stem cell transplantation, may be employed to improve the disease outcome. John Libbey Eurotext 2022-09-12 2022 /pmc/articles/PMC9465665/ /pubmed/36069176 http://dx.doi.org/10.1684/ejd.2022.4281 Text en © JLE/Springer 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Report
Dolezalova, Karolina
Strachan, Tomas
Matej, Radoslav
Ricna, Dita
Bloomfield, Marketa
Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNγ immunity
title Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNγ immunity
title_full Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNγ immunity
title_fullStr Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNγ immunity
title_full_unstemmed Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNγ immunity
title_short Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNγ immunity
title_sort manifestations of cutaneous mycobacterial infections in patients with inborn errors of il-12/il-23-ifnγ immunity
topic Clinical Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465665/
https://www.ncbi.nlm.nih.gov/pubmed/36069176
http://dx.doi.org/10.1684/ejd.2022.4281
work_keys_str_mv AT dolezalovakarolina manifestationsofcutaneousmycobacterialinfectionsinpatientswithinbornerrorsofil12il23ifngimmunity
AT strachantomas manifestationsofcutaneousmycobacterialinfectionsinpatientswithinbornerrorsofil12il23ifngimmunity
AT matejradoslav manifestationsofcutaneousmycobacterialinfectionsinpatientswithinbornerrorsofil12il23ifngimmunity
AT ricnadita manifestationsofcutaneousmycobacterialinfectionsinpatientswithinbornerrorsofil12il23ifngimmunity
AT bloomfieldmarketa manifestationsofcutaneousmycobacterialinfectionsinpatientswithinbornerrorsofil12il23ifngimmunity